A Phase 2 interventional study of The dual therapy and The triple therapy in Failure After Assisted Reproductive Technology, sponsored by Chengdu University of Traditional Chinese Medicine. Completed at 1 site in China. Open to female participants aged 24 Years to 43 Years. Per ClinicalTrials.gov, last updated 2017-03-10.
Sponsored by Chengdu University of Traditional Chinese Medicine · Phase 2, Interventional, and Treatment
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan.
Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan.
Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.
The results will show the effect of TCM multi-channel interventional therapy for patients with ART failure
Chengdu University of Traditional Chinese Medicine is the lead sponsor of 57 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No Intervention
TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy.
Other: The dual therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM.
Other: The triple therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM
Proportion of patients with sucessful conception
Time frame: 10 weeks after embryo transplantation
Time to have successful conception
Time frame: up to 26 weeks
Adverse events
Time frame: 0, 10, 26 weeks after randomization
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chengdu University of Traditional Chinese Medicine